跳至主要内容
临床试验/NL-OMON36981
NL-OMON36981已完成不适用

Single-center, open label, multiple dose study to investigate the pharmacokinetics of RO5186582 given BID over 28 days, and in addition, the excretion and metabolism of [13C]- labelled IV microdoses and an oral [14C]-labelled dose of RO5186582 in Healthy Male Volunteers - [13C]- and [14C]-RO5186582 absolute bioavailability study

Hoffmann-La Roche0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy male
  • 30-55 yrs, inclusive
  • BMI: 18.0-30.0 kg/m2, inclusive
  • non-smoking or smoking < 5 cigarettes/day

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study

研究者

相似试验

Single-center, open label, multiple dose study to... | 临床试验